Related Experiment Video
Updated: Mar 26, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Risk factors for radiation exposure in newly diagnosed IBD patients
David J Grand1,2, Adam Harris3, Jason Shapiro4
1Alpert Medical School, Brown University, Providence, RI, USA. dgrand@lifespan.org.
Patients with inflammatory bowel disease (IBD) face significant diagnostic radiation exposure. Risk factors like GI surgery and specific disease types increase this exposure, guiding physicians toward safer imaging choices.
Area of Science:
- Medical Imaging
- Gastroenterology
- Radiation Oncology
Background:
- Patients diagnosed with inflammatory bowel disease (IBD) may undergo numerous diagnostic imaging procedures.
- Diagnostic radiation exposure is a concern for IBD patients, particularly with advanced disease or complications.
Purpose of the Study:
- To identify specific patient subsets within the inflammatory bowel disease population who are at higher risk for significant diagnostic radiation exposure.
- To inform clinical practice regarding radiation safety in IBD management.
Main Methods:
- A prospective study of 336 newly diagnosed IBD patients (adult and pediatric) enrolled in the Ocean State Crohn's & Colitis Area Registry (OSCCAR).
- Comprehensive chart review was conducted to assess diagnostic radiation exposure and identify associated risk factors.
- Statistical analysis was performed to determine the significance of various clinical factors on radiation dose.
Main Results:
- Over half of the IBD patients (57.1%) received GI-specific radiation, with higher doses in adults compared to pediatric patients.
- Crohn's disease (CD) patients, particularly those with stricturing or penetrating disease, received significantly higher radiation doses than ulcerative colitis (UC) patients.
- Key risk factors for increased radiation exposure included prior GI surgery, biologic therapy, pain-predominant symptoms, and isolated ileal disease.
Conclusions:
- Several clinical factors are associated with elevated ionizing radiation exposure in IBD patients.
- Identifying these risk factors allows for proactive patient stratification and consideration of alternative, lower-dose, or radiation-free imaging modalities.
- This knowledge supports personalized radiation safety strategies in the management of inflammatory bowel disease.
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

